|
Forecast Period
|
2026-2030
|
|
Market Size (2024)
|
USD
9.71 Billion
|
|
CAGR (2025-2030)
|
6.27%
|
|
Fastest Growing Segment
|
Ultrasound
Systems
|
|
Largest Market
|
China
|
|
Market Size (2030)
|
USD 14.02 Billion
|
Market Overview
Asia Pacific Diagnostic Imaging Market was valued at USD 9.71 Billion in 2024 and is expected to reach USD 14.02 Billion by 2030, growing with a CAGR of 6.27% in the forecast period. The Asia Pacific diagnostic imaging market is
experiencing robust growth, driven by a confluence of demographic shifts,
increasing healthcare expenditure, and the rapid adoption of advanced imaging
technologies. Diagnostic imaging, encompassing modalities such as X-ray,
computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, and
nuclear imaging, plays a critical role in disease diagnosis, monitoring, and
treatment planning across a wide range of clinical conditions. As the region
transitions towards value-based healthcare, the demand for early and accurate
diagnosis is fueling investments in imaging infrastructure and services.
A key driver of market growth in Asia Pacific is
the rising burden of chronic diseases, including cancer, cardiovascular
disorders, and neurological conditions. According to the World Health
Organization (WHO), non-communicable diseases account for over 60% of total
deaths in the region. Early diagnosis through imaging has become vital to
curbing disease progression and improving patient outcomes. Additionally,
growing geriatric populations in countries such as Japan, China, and South
Korea are further increasing the need for diagnostic services, as aging
individuals are more prone to health complications requiring imaging support. The
market is also benefiting from the digital transformation of healthcare
systems, with artificial intelligence (AI)-enabled imaging solutions gaining
traction. AI is being increasingly integrated into imaging equipment and
radiology workflows to enhance image interpretation, reduce diagnostic errors,
and optimize reporting speed. Countries such as China and India are witnessing
a surge in AI-based imaging start-ups and partnerships between technology firms
and healthcare providers, signaling a shift towards more efficient and
data-driven diagnostics.
Public and private investments in healthcare
infrastructure are accelerating the adoption of imaging technologies across
both urban and rural areas. Governments across the region are prioritizing
access to essential diagnostic tools through initiatives such as India’s
Ayushman Bharat and China’s Healthy China 2030. Moreover, the emergence of
mobile imaging units and teleradiology services is helping bridge the
diagnostic gap in underserved regions, offering significant market potential
for equipment manufacturers and service providers. Despite these growth
enablers, the market faces certain challenges, including high equipment costs,
limited availability of skilled radiologists, and disparities in access to
imaging services between urban and rural regions. Regulatory complexities and varying
reimbursement policies across countries also pose hurdles to uniform market
penetration. However, ongoing advancements in portable and low-cost imaging
technologies, along with training initiatives and cross-border collaborations,
are gradually mitigating these concerns.
Key Market Drivers
Rising Geriatric Population and Chronic Disease
Burden are Driving the Asia Pacific Diagnostic Imaging Market
The Asia Pacific diagnostic imaging market is
witnessing significant growth, underpinned by a rapidly aging population and
the escalating prevalence of chronic diseases. With nations across the region
experiencing a demographic shift toward older age groups, the demand for
advanced diagnostic tools is intensifying. This evolving landscape is
presenting lucrative opportunities for imaging technology providers, healthcare
institutions, and investors aiming to tap into one of the most dynamic
healthcare markets globally.
Asia Pacific is home to over 60% of the global
population, and countries such as Japan, China, South Korea, and Australia are
seeing a pronounced increase in their elderly population. According to the
United Nations, by 2050, one in four people in Asia will be over the age of 60.
This demographic transition is resulting in a higher incidence of age-related
conditions such as osteoporosis, cardiovascular diseases, cancers, and
neurodegenerative disorders—all of which require timely and accurate imaging
for diagnosis and ongoing management.
Japan, for instance, already qualifies as a
“super-aged” society, with more than 28% of its population aged 65 and above. This has led to a significant increase in the
deployment of modalities such as CT scans, MRI, and ultrasound to detect and
monitor chronic conditions at early stages. In addition to aging, the Asia
Pacific region is experiencing a surge in non-communicable diseases (NCDs),
driven by urbanization, sedentary lifestyles, changing dietary patterns, and
increased life expectancy. The World Health Organization (WHO) estimates
that NCDs account for over 70% of all deaths in the region. Cardiovascular
diseases, diabetes, cancer, and respiratory ailments are particularly
prevalent. As a result, diagnostic imaging is becoming an indispensable
component of clinical workflows. Imaging technologies play a vital role in
early disease detection, treatment planning, and monitoring of disease
progression. For example, cancer care pathways now rely heavily on PET-CT and
MRI for tumor localization, staging, and therapy response assessment.
Rising Medical Tourism
The Asia Pacific diagnostic imaging market is
experiencing significant growth, and one of the key drivers behind this upward
trend is the increasing influx of medical tourists to the region. With
countries like India, Thailand, Singapore, Malaysia, and South Korea emerging
as global healthcare destinations, the demand for advanced diagnostic imaging
services is witnessing a robust surge.
Patients from across North America, Europe, the
Middle East, and Africa are increasingly choosing Asia Pacific nations for
medical treatments, owing to a combination of factors — affordability,
high-quality care, shorter waiting periods, and access to technologically
advanced healthcare infrastructure. Diagnostic imaging, which plays a critical
role in early and accurate diagnosis, has become a fundamental component of
this medical value proposition. For instance, magnetic resonance imaging (MRI),
computed tomography (CT) scans, positron emission tomography (PET), and
ultrasound imaging are widely offered in the region at a fraction of the cost
charged in Western countries. This cost efficiency, without compromising on
service quality, has proven to be a key differentiator.
To accommodate the rising demand from international
patients, several Asia Pacific nations have accelerated investments in
upgrading diagnostic imaging technologies. Leading private hospital chains and
diagnostic centers are enhancing their capabilities with high-end imaging
systems, artificial intelligence (AI)-enabled imaging software, and integrated
radiology platforms to offer seamless and efficient diagnostics. Moreover,
governments in the region are increasingly supporting public-private
partnerships (PPPs) to boost healthcare infrastructure. In India, for example,
the government’s Ayushman Bharat initiative and supportive FDI policies have
encouraged private investments in diagnostic imaging. Similarly, Thailand’s
“Medical Hub” policy and Malaysia’s healthcare travel initiatives are expanding
diagnostic capabilities to serve a growing international patient base.
Download Free Sample Report
Key Market Challenges
Shortage of Trained
Radiologists and Technologists
One of the most pressing issues in the Asia Pacific
region is the scarcity of qualified radiologists and imaging professionals.
Rapid urbanization has led to a growing patient base, but workforce development
has not kept pace. Countries such as the Philippines, Thailand, and Malaysia
report a radiologist-to-patient ratio far below global standards. This talent
gap limits the efficiency and accuracy of diagnostic imaging services, thereby
affecting clinical outcomes.
Key Market Trends
Technological Advancements and Innovation
The Asia Pacific diagnostic imaging market is
undergoing significant transformation, largely fueled by rapid technological
advancements across imaging modalities. As healthcare infrastructure expands
and clinical demands grow more sophisticated, innovations in diagnostic imaging
are reshaping the landscape, enhancing diagnostic accuracy, improving patient
outcomes, and optimizing workflow efficiencies across the region.
Healthcare systems across Asia Pacific are
witnessing a growing demand for advanced imaging solutions such as magnetic
resonance imaging (MRI), computed tomography (CT), positron emission tomography
(PET), and hybrid modalities. This surge is driven by a rising burden of
chronic diseases, an aging population, and increasing awareness of early and
accurate diagnosis. These factors are encouraging hospitals and diagnostic
centers to upgrade their imaging equipment with state-of-the-art technologies
that provide higher resolution, faster scan times, and lower radiation
exposure. One of the most impactful developments in the market is the
integration of artificial intelligence (AI) and machine learning into imaging
modalities. AI-powered diagnostic platforms are now capable of automating image
interpretation, detecting abnormalities with high precision, and assisting
radiologists in delivering faster and more consistent results. These
technologies are not only streamlining workflows but also addressing the
shortage of skilled radiologists in several emerging economies across Asia. For
example, AI algorithms are increasingly used in chest X-rays to detect
early-stage tuberculosis and lung cancer, especially in rural or
resource-constrained settings. Moreover, major players are launching AI-enabled
imaging systems tailored for Asia Pacific markets, enhancing the scalability
and affordability of diagnostic services.
Hybrid imaging modalities, such as PET/CT and
PET/MRI, are gaining traction due to their ability to provide both anatomical
and functional information in a single scan. This comprehensive view is proving
invaluable in oncology, cardiology, and neurology applications. Additionally,
the demand for portable and point-of-care imaging devices is expanding,
especially in remote and underserved areas where traditional imaging
infrastructure is limited. These innovations are making diagnostic services
more accessible and cost-effective, thus broadening the market reach. Governments
across Asia Pacific are actively promoting healthcare modernization through
strategic investments, policy frameworks, and public-private partnerships.
National programs aimed at expanding radiology networks and deploying advanced
imaging systems in public hospitals are driving market growth. Countries such
as China, India, Japan, and South Korea are spearheading initiatives to
digitize their healthcare systems, which includes substantial investments in
diagnostic imaging infrastructure.
Segmental Insights
Route of Administration Insights
Based on the category of type, the Ultrasound
Systems category had the highest share of revenue in 2024. Ultrasound systems are highly versatile and
non-invasive diagnostic tools that are widely used across multiple specialties,
including obstetrics and gynecology, cardiology, urology, and general imaging.
In the Asia Pacific region—where maternal and neonatal healthcare is a priority
in countries such as India, China, and Southeast Asia—ultrasound plays a
critical role in prenatal and fetal monitoring. Moreover, the technology's
applicability in both preventive care and chronic disease management has expanded
its usage across outpatient and primary care settings, boosting overall demand.
Compared to other advanced imaging modalities such as MRI or CT, ultrasound
systems are relatively low-cost and portable, making them ideal for
resource-constrained and rural healthcare settings, which are prevalent in many
parts of the Asia Pacific region. Governments and healthcare providers are
increasingly investing in portable ultrasound machines to support outreach and
community health programs. The affordability and ease of maintenance also make
them an attractive choice for private clinics and diagnostic centers.
Mobility Insights
Based on the category of Mobility, the Standalone category
secured the largest share of revenue in 2024. Standalone diagnostic imaging
systems are primarily installed in hospitals, diagnostic centers, and specialty
clinics—facilities that form the backbone of healthcare delivery in most Asia
Pacific countries. These institutions already have the physical infrastructure,
radiology personnel, and electrical and environmental setup necessary to house
and operate fixed imaging systems such as MRI machines, CT scanners, and
high-end ultrasound devices. Countries like China, Japan, South Korea, and
India have made significant investments in their healthcare infrastructure,
which has fueled the widespread adoption of these standalone systems. Standalone
systems are often preferred for their high-resolution imaging capabilities,
better throughput, and advanced software integration. They are capable of
performing complex diagnostic procedures that require high imaging fidelity and
precision—something not always achievable with mobile or portable systems. For
chronic diseases such as cancer, neurological disorders, and cardiovascular
conditions—which are on the rise in the Asia Pacific region—hospitals and
diagnostic centers rely on high-end, stationary equipment to ensure accurate
diagnosis and follow-up.
Download Free Sample Report
Regional Insights
In 2024, China held the largest market share in
terms of revenue, driven by a combination of demographic, economic, and
technological factors. One of the most significant contributors is the
country’s vast and aging population. China is experiencing a surge in
age-related and chronic health conditions such as cancer, cardiovascular
diseases, and diabetes, all of which require consistent and accurate imaging
diagnostics. With the elderly population growing rapidly—projected to
surpass 400 million people aged 60 and above by 2040—the demand for imaging
tools like CT scans, MRIs, PET scans, and ultrasounds has increased
substantially. Another major factor is the Chinese government's commitment to
improving healthcare infrastructure through long-term policies such as the
"Healthy China 2030" initiative and the “One Thousand Counties
Project.” These programs aim to expand access to quality medical care across
rural and urban areas by equipping hospitals and diagnostic centers with
advanced imaging equipment. Massive public investments have supported the
construction of national-level imaging centers and collaborations with global
technology firms, accelerating the deployment of state-of-the-art systems
across the country.
Recent Developments
- Nawaloka Hospitals PLC, a leading private healthcare provider in Sri Lanka, has achieved a significant milestone with the launch of South Asia’s first Artificial Intelligence (AI)-enabled Canon Vantage Orian MRI scanner. Officially commissioned on March 18, 2025, this cutting-edge installation further strengthens Nawaloka Hospitals’ position as a frontrunner in medical innovation and advanced patient care.This strategic investment, totaling USD 4.5 million and including a comprehensive upgrade of the radiology diagnostic infrastructure, underscores the hospital’s commitment to delivering world-class healthcare. The integration of AI-driven MRI technology enhances diagnostic accuracy, accelerates imaging processes, and supports early disease detection, aligning Nawaloka’s radiology services with global best practices.
- In February 2025, SGX Catalist-listed AsiaMedic Limited, in collaboration with Sunway Equity Holdings Pte. Ltd.—a wholly owned subsidiary of the Malaysian conglomerate Sunway Group—formally launched AsiaMedic Sunway Imaging, a state-of-the-art medical diagnostics imaging centre located at Royal Square in Novena. This development marks a strategic expansion of the Group’s diagnostic imaging capabilities. The new centre spans approximately 6,000 square feet and is equipped with cutting-edge medical imaging technology. It offers a wide spectrum of diagnostic imaging services, including computed tomography (CT) and magnetic resonance imaging (MRI), with a particular emphasis on sub-specialised radiology. These services are delivered by a team of highly experienced radiologists, ensuring high-quality, patient-centric care.
- In January 2025, Siemens Healthineers, a global leader in medical technology, showcased its latest diagnostic imaging innovations at the 23rd Asian Oceanian Congress of Radiology (AOCR) held in Chennai. The event, organized by the Tamil Nadu and Pondicherry chapter of the Indian Radiological and Imaging Association (IRIA), served as a prominent platform for presenting cutting-edge advancements in imaging technology.
- In December 2024, Royal Philips, a global leader in health technology, announced a strategic collaboration with Singapore General Hospital (SGH) to establish a pioneering Magnetic Resonance Imaging (MRI) Training Centre in Singapore. Launching on December 9, 2024, this initiative supports SGH’s commitment to advancing medical imaging education and expertise. The center will be accessible to both public and private healthcare institutions across Singapore and the broader Asia-Pacific (APAC) region.
Key Market Players
- Wipro GE Healthcare Pvt. Ltd. (GE Healthcare Limited)
- Siemens Healthcare Private Limited
- Canon Medical Systems Corporation
- Hitachi Ltd.
- FUJIFILM Holdings Corporation
- Mindray Medical International Ltd.
- Shimadzu Corporation
- Allengers Medical Systems Limited
- Hologic Hub Ltd.
- Koninklijke Philips N.V.
|
By Type
|
By Mobility
|
By Source
|
By Application
|
By End User
|
By Country
|
- X-Ray Imaging Solutions
- Ultrasound Systems
- MRI Systems
- CT Scanners
- Nuclear Imaging Solutions
- Mammography
- Others
|
|
|
- Cardiology
- Oncology
- Neurology
- Orthopedics
- Gastroenterology
- Gynecology
- Others
|
- Hospitals & Clinics
- Diagnostic Centers
- Ambulatory Care Centers
- Others
|
- China
- India
- Japan
- South Korea
- Australia
- Singapore
- Malaysia
- Thailand
- Vietnam
- Indonesia
|
Report Scope:
In this report, the Asia Pacific Diagnostic Imaging
Market has been segmented into the following categories, in addition to the
industry trends which have also been detailed below:
- Asia Pacific Diagnostic
imaging Market, By
Type:
o X-Ray Imaging Solutions
o Ultrasound Systems
o MRI Systems
o CT Scanners
o Nuclear Imaging Solutions
o Mammography
o Others
- Asia Pacific Diagnostic
imaging Market, By
Mobility:
o Portable
o Standalone
- Asia Pacific Diagnostic Imaging
Market, By
Source:
o Domestic
o Import
- Asia Pacific Diagnostic Imaging
Market, By
Application:
o Cardiology
o Oncology
o Neurology
o Orthopedics
o Gastroenterology
o Gynecology
o Others
- Asia Pacific Diagnostic Imaging
Market, By
End User:
o Hospitals & Clinics
o Diagnostic Centers
o Ambulatory Care Centers
o Others
- Asia Pacific Diagnostic Imaging
Market, By Country:
o China
o India
o Japan
o South Korea
o Australia
o Singapore
o Malaysia
o Thailand
o Vietnam
o Indonesia
Competitive Landscape
Company Profiles: Detailed analysis of the major companies
present in the Asia Pacific Diagnostic Imaging Market.
Available Customizations:
Asia Pacific Diagnostic Imaging Market Report with
the given market data, Tech Sci Research offers customizations according to a
company's specific needs. The following customization options are available for
the report:
Company Information
- Detailed analysis and
profiling of additional market players (up to five).
Asia Pacific Diagnostic
imaging Market is an upcoming report to be released soon. If you wish an early
delivery of this report or want to confirm the date of release, please contact
us at [email protected]